ATLANTA, June 2, 2026 /PRNewswire/ -- Invesco Ltd. (NYSE: IVZ), a leading global asset management firm, announced today that Allison Dukes, Chief Financial Officer,...
CHARLESTON, W.Va., Aug. 15, 2025 /PRNewswire/ -- Surya Oil & Gas Corp. (OTCID: CNRC), ( "SOGC" or the "Company" ) formerly known as Cunningham Natural...
AUSTIN, Texas and NEW YORK, Aug. 15, 2025 (GLOBE NEWSWIRE) -- T1 Energy Inc. (NYSE: TE) (“T1,” “T1 Energy,” or the “Company”) announced this morning that the Company has rescheduled its second quarter earnings release and conference call to August 20, 2025. T1’s decision to reschedule the earnings release is to accommodate the Company’s decision to delay the filing of its Quarterly Report on Form 10-Q as permitted under SEC Rules. The Company filed a Form 12b-25 notifying the U.S. Securities and Exchange Commission earlier today.
SARASOTA, Fla., Aug. 14, 2025 (GLOBE NEWSWIRE) -- INVO Fertility, Inc. (Nasdaq: IVF) (“INVO Fertility” or the “Company”), a healthcare services fertility company focused on expanding access to advanced treatment through the establishment, acquisition and operation of fertility clinics and related businesses and technologies, today announced second quarter 2025 financial results.
The Group published today the Consolidated Interim Report for II Quarter and 6 Months of 2025 (Unaudited). In the stock exchange notice and in the respective section “Key financials” of the report, it was erroneously stated that the result for the second quarter was a net loss, whereas the actual result was a net profit of EUR 4.3 million. Therefore, we are publishing again both the corrected notice and the amended report.
The Group published today the Consolidated Interim Report for II Quarter and 6 Months of 2025 (Unaudited). In the stock exchange notice and in the respective section “Key financials” of the report, it was erroneously stated that the result for the second quarter was a net loss, whereas the actual result was a net profit of EUR 4.3 million. Therefore, we are publishing again both the corrected notice and the amended report.
"With cutting-edge advances in next-generation sequencing and growing interest in personalized medicine, whole genome sequencing is set to transform disease diagnosis and treatment, driving...
EQT to sell Nexon Asia Pacific, a leading digital and IT services provider in Australia that delivers end-to-end solutions for the mid-market and enterprise...